Reply to "Comment on Casiraghi et al. 'Mucoadhesive Budesonide Formulation for the Treatment of Eosinophilic Esophagitis' 2020, , 211".

The paper entitled "Mucoadhesive Budesonide Formulation for the Treatment of Eosinophilic Esophagitis 2020, , 211" discusses the physicochemical and technological characterization of a formulation to treat eosinophilic esophagitis [...

Mucoadhesive Budesonide Formulation for the Treatment of Eosinophilic Esophagitis.

Eosinophilic esophagitis (EE) is a chronic immune/antigen-mediated esophageal inflammatory disease for which off-label topical corticosteroids (e.g., budesonide) are widely used in clinic.